MSB 10.4% $1.49 mesoblast limited

Ann: Key Day 100 Survival Results In P3 GvHD Trial, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,124 Posts.
    lightbulb Created with Sketch. 1063
    What a magnificent event to present these wonderful numbers to the biggest stem cell event in the world.

    http://www.isscr.org/meetings-event...meeting-2018/program/2018-program-book-errata

    2018 ISSR Annual Meeting

    20-23 June, 2018
    Melbourne Convention & Exhibition Centre
    Melbourne, Australia


    Wednesday, 20 June

    Plenary II: Recapitulating Development from Stem Cells 16:00-18:00
    Nissim Benvenisty, Hebrew University, Israel
    HAPLOID HUMAN EMBRYONIC STEM CELLS: DERIVATION AND APPLICATIONS

    Thursday, 21 June
    Concurrent IA: Mechanisms of Reprogramming 1: to pluripotency (13:15 to 15:15)
    14:30 - 14:45 Abstract-selected speaker
    Jian Shu, Broad Institute/Whitehead Institute, MA, U.S.
    RECONSTRUCTION OF CELLULAR REPROGRAMMING LANDSCAPES AND TRAJECTORIES BY ANALYSIS OF LARGE-SCALE SINGLE-CELL GENE EXPRESSION

    Concurrent IE: Homeostasis, Metabolism and Aging (13:15 to 15:15)
    Session Chair: Amy Wagers, Harvard University, U.S.
    13:15 – 13:20 Topic Overview by Chair

    Concurrent IIC: Road to the Clinic I (16:00- 18:00)
    17:15-17:30 Roger Barker, University of Cambridge, U.K.
    LESSONS LEARNED FROM A CELL-BASED TRIAL IN PARKINSON’S DISEASE


    17:30-17:55 Silviu Itescu, Mesoblast LTD., Australia
    ROAD TO THE CLINIC: THE COMMERCIALIZATION OF MESENCHYMAL LINEAGE CELLS



    Concurrent IID: Tissue Engineering (16:00- 18:00)
    Session Chair: Mattias Lutolf, École Polytechnique Fédérale de Lausanne (EFPL), Switzerland
    16:00 – 16:05 Topic Overview by Chair


    Friday, 22 June
    Plenary IV: New Technologies in Stem Cell Engineering
    9:00 to 9:25: Fred H. Gage, Salk Institutes for Biological Studies, U.S.
    IN VIVO BRAIN ORGANOID MODEL OF VASCULARIZED AND FUNCTIONAL PSC-DERIVED HUMAN BRAIN ORGANOIDS


    Saturday, 22 June
    Plenary VI: Cancer Stem Cells
    10:40 – 11:05: Leonard I. Zon, Boston Children's Hospital, U.S.
    THE START OF CANCER - STEM CELL CHANGES, CLONAL EXPANSION AND NICHE REGULATION
    Concurrent IVA: Road to the Clinic 2 (13:15 to 15:15)
    Session Chair: Robert Deans, BlueRock Therapeutics, U.S.
    13:15 – 13:20 Topic Overview by Chair

    Concurrent IVB: Epigenetics and Genetic Regulatory Networks
    13:20-13:45: Jose Polo, Monash University, Australia
    CHROMATIN AND TRANSCRIPTION FACTOR DYNAMICS DURING REPROGRAMMING

    ISSCR.PNG
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.49
Change
0.140(10.4%)
Mkt cap ! $1.701B
Open High Low Value Volume
$1.37 $1.54 $1.37 $23.10M 15.82M

Buyers (Bids)

No. Vol. Price($)
3 24758 $1.49
 

Sellers (Offers)

Price($) Vol. No.
$1.49 73626 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.